Delayed childbearing and female ageing impair assisted reproductive technology outcome in survivors of male haematological cancers
To analyse the impact of female characteristics on assisted reproductive technology outcome among male haematological cancer survivors.
A retrospective analysis of 93 haematological cancer survivors attending our tertiary referral fertility centre between June 1998 and June 2017 for achieving fatherhood with assisted reproductive technology treatments.
A progressive increase in the median female age was observed during the study period (32.2 years until the year 2007 and 36.9 years from the year 2012). Fifty-five out of 93 patients were treated with intracytoplasmic sperm injection (ICSI) (113 ovarian stimulations, 108 ICSI procedures). Cryopreserved ejaculated sperm was used in 28 couples, fresh sperm in 19, and thawed testicular sperm in 8 couples. Mean female age at ovarian stimulation was 37.0 ± 4.7 years. Twenty-six pregnancies resulted in a full-term birth (23% per started ovarian stimulation; 43.6% per couple) and 33 children were born. No significant differences were observed according to source of sperm (fresh, frozen, testicular) and multivariate analysis confirmed that maternal age was the only variable inversely related to the cumulative delivery rate, being five times lower (15.7%) when the female partner was ≥ 40 years (OR = 0.22, 95% CI 0.06–0.77) vs. 58.3% with younger women (p = 0.0037).
Delayed childbearing and female ageing affect ICSI outcome in couples where the male is a survivor of haematological cancer. This topic should be discussed when counselling male cancer patients about fertility preservation.
KeywordsAssisted reproductive technology Haematological cancer Male infertility Delayed childbearing Sperm banks
The authors thank Pasquale Patrizio, M.D., M.B.E., Yale University, Fertility Center, for helping in preparing this manuscript.
Compliance with ethical standards
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Conflict of interest
The authors declare that they have no conflicts of interest.
- 11.World Health Organization. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction, vol. viii. 3rd ed. Cambridge: Published on behalf of the World Health Organization by Cambridge University Press; 1992. 107p pGoogle Scholar
- 12.World Health Organization. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction, vol. x. 4th ed. Cambridge: Published on behalf of the World Health Organization by Cambridge University Press; 1999. 128p pGoogle Scholar
- 13.World Health Organization DoRHaR. WHO laboratory manual for the examination and processing of human semen. Fifth edition ed; 2010. 287 pGoogle Scholar
- 17.Hendriks DJ, Mol BW, Bancsi LF, Te Velde ER, Broekmans FJ. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril. 2005;83(2):291–301.CrossRefPubMedGoogle Scholar
- 28.ISTAT. Births and fertility among the resident population 2015 [Available from: http://www.istat.it/en/files/2016/11/EN_Births_Fertility_2015.pdf?title=Birth+and+fertility+-+28+Nov+2016+-+Full+text.pdf.
- 29.Newsrelease E. Birth and fertility, over 5 million babies born in the EU in 2015. Women first became mothers at almost 29 on average 2017 [Available from: http://ec.europa.eu/eurostat/documents/2995521/7898237/3-08032017-AP-EN.pdf/b17c1516-faad-4e65-b291-187826a7ac88.